We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Cardiogenic shock: a lethal complication of acute myocardial infarction.
Cardiogenic shock is a serious complication of myocardial infarction (MI) that affects approximately 7% of MI patients, accounting for the majority of all deaths related to acute infarction. Shock is typically the result of a massive amount of damage to the left ventricular myocardium; its defining characteristics are hypotension (systolic blood pressure [SBP] of 90 mm Hg or less, or in chronically hypertensive patients a drop in SBP of 30 mm Hg or more) and hypoperfusion. Shock occurs more frequently in ST-segment elevation MI (STEMI) patients than in non-STEMI patients. Revascularization, either with angioplasty or coronary bypass graft surgery, is associated with better outcomes than intensive medical therapy in patients with shock. Adjunctive therapies include vasopressor therapy, mechanical ventilatory support, and intra-aortic balloon pump counterpulsation (IABP). IABP can stabilize some patients and may make revascularization safer. Other adjunctive therapies being investigated include improved mechanical support devices, induction of systemic hypothermia, use of supersaturated oxygen, and, as medical therapy, administration of L-NMMA.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app